SCHEMBL2494548

SCHEMBL2494548

CCN(CC)c1ccccc1[CH]c1ccccc1N(CC)CC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.39
MAPT P10636 6/20 0.37
ALDH1A1 P00352 5/20 0.37
MEN1 O00255 3/20 0.37
LMNA P02545 3/20 0.37
KMT2A Q03164 3/20 0.37
KDM4E B2RXH2 2/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
THRB P10828 1/20 0.37
PTBP1 P26599 1/20 0.37
ALDH1A3 P47895 2/20 0.36
ALDH3A1 P30838 2/20 0.35
CNR2 P34972 1/20 0.35
AR P10275 2/20 0.35
NR3C1 P04150 1/20 0.35
PGR P06401 1/20 0.35
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
CYP3A4 P08684 4/20 0.33
TDP1 Q9NUW8 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2492760 0.85 CRHR1 (0.39) ALDH1A1ALDH1A3ALDH3A1
SCHEMBL136177 0.82 ALDH1A1 (0.41) TSHRMAPTALDH1A1MEN1LMNA
SCHEMBL29354732 0.82 KMT2A (0.50) TSHRMAPTALDH1A1MEN1LMNA
SCHEMBL465195 0.82 KMT2A (0.50) TSHRMAPTALDH1A1MEN1LMNA
SCHEMBL7665163 0.82 TSHR (0.36) TSHRMAPTALDH1A1MEN1LMNA
SCHEMBL31718395 0.82 TSHR (0.46) TSHRMAPTALDH1A1MEN1LMNA
SCHEMBL6299189 0.82 TSHR (0.46) TSHRMAPTALDH1A1MEN1LMNA
SCHEMBL2491664 0.81 TDP1 (0.37) MAPTALDH1A1MEN1LMNAKMT2A
SCHEMBL13778825 0.79 APP (0.43) MAPTALDH1A1MEN1LMNAKMT2A
SCHEMBL15387861 0.79 TSHR (0.34) TSHRMAPTALDH1A1MEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2380567-B1 MELANIN PRODUCTION INHIBITOR POLA CHEM IND INC (JP) 2019-01-16 EP disclosed
EP-3009123-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2016-04-20 EP disclosed
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2015-11-19 US disclosed
EP-2845587-A2 Melanin production inhibitor Pola Chemical Industries Inc. (JP) 2015-03-11 EP disclosed
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2014-12-11 US disclosed
US-8846012-B2 Melanin production inhibitor POLA CHEMICAL INDUSTRIES INC. (JP) 2014-09-30 US disclosed
EP-2380567-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2011-10-26 EP disclosed
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, TH TSHR 100/4885MAPT 3454/4885ALDH1A1 1292/4885
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR TYR, MC1R, F12 TSHR 75/4885MAPT 3294/4885ALDH1A1 1031/4885
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, MC1R TSHR 68/4885MAPT 3128/4885ALDH1A1 1187/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.